Untreated NASH animals had significantly reduced biliary secretion of BA and increased fecal excretion of BA via decreased apical sodium-dependent bile salt transporter (Asbt)-mediated reabsorption. Here, SLC10A2 is linked to metabolic dysfunction-associated steatohepatitis.